Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
Nicholas K. Hurlburt, Leah J. Homad, Irika Sinha, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 204
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Jasmin Quandt, Alexander Muik, Nadine Salisch, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 187
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
Pan-Pan Zhou, Meng Yuan, Ge Song, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 637
Open Access | Times Cited: 162
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 122
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 113
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Nature (2024) Vol. 630, Iss. 8018, pp. 950-960
Closed Access | Times Cited: 29
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 33
The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
Joel D. Allen, Dylan P. Ivory, Ge Song, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112307-112307
Open Access | Times Cited: 22
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Timothy J.C. Tan, Zongjun Mou, Ruipeng Lei, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Structure and inhibition of SARS-CoV-2 spike refolding in membranes
Michael W. Grunst, Zhuan Qin, Esteban Dodero‐Rojas, et al.
Science (2024) Vol. 385, Iss. 6710, pp. 757-765
Closed Access | Times Cited: 13
Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes
Jonathan Hurtado, Thomas F. Rogers, David B. Jaffe, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114307-114307
Open Access | Times Cited: 9
Broadly neutralizing antibodies against COVID-19
Daming Zhou, Jingshan Ren, Elizabeth E. Fry, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101332-101332
Open Access | Times Cited: 19
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans
David Chmielewski, Eric Wilson, Grigore Pintilie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-COV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
(2024)
Open Access | Times Cited: 6
Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting
Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109363-109363
Open Access | Times Cited: 5
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses
Theocharis Tsoleridis, Chengcheng Fan, Emily J. Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses
Bo Feng, Cuiyun Li, Zhaoyong Zhang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon
Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Virology (2025) Vol. 605, pp. 110467-110467
Closed Access
Unveiling the Complete Spectrum of SARS-CoV-2 Fusion Stages by In Situ Cryo-ET
Caner Akıl, Jialu Xu, Juan Shen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
Pan-Pan Zhou, Meng Yuan, Ge Song, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 39
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S. Piepenbrink, Jun‐Gyu Park, Ashlesha Deshpande, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 7, pp. e1010691-e1010691
Open Access | Times Cited: 26
CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses
Bezawit A. Woldemeskel, Arbor G. Dykema, Caroline C. Garliss, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top